Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Virtus

PCVAX Expense Ratio & Fees

Ticker PCVAX · · Holdings as of Jun 30, 2026

Expense ratio
1.17%$117/yr per $10k
5-yr return
+5.3%annualized
1-yr return
−4.5%as of Dec 2025
Net assets
$258.5Mall share classes
Holdings
78

Bottom line

What is PCVAX's expense ratio?

PCVAX's expense ratio is 1.17%, or about $117 a year on every $10,000 invested. That is more expensive than 67% of small-cap funds we track (median 0.99%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.

Updated Oct 22, 2026

PCVAX fee table

Net expense ratio1.17%
Gross expense ratio1.21%
Management fee0.6%
12b-1 (distribution) fee0.25%
Other expenses0.36%
Fee waiver / reimbursement-0.04%
Max front-end sales load5.5%
Max deferred sales charge0%

Source: Fund prospectus fee table, filed Oct 22, 2026

What PCVAX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
PCVAX$663$909$1,175$1,932

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 1.17% expense ratio costs roughly $63,800 in lost growth, versus about $54,900 for the median small-cap fund (0.99%).

Cheapest way to own Virtus NFJ Small-Cap Value Fund

All share classes
TickerClassExpense ratioFront load
ANFVXR60.77%0%
PSVIXInstitutional0.82%0%
PCVAXA1.17%5.5%
PCVCXC1.92%0%